Journal for ImmunoTherapy of Cancer (Nov 2023)

476 Development of a flow cytometric receptor occupancy assay for clinical analysis of immune checkpoint inhibitor therapeutics

Maria Mancini,
Mara Gilardi,
Karin Abarca Heidemann,
Michael Ritchie,
Brandon Walling,
Haoting Hsu,
Jessica Pearl,
Megan Richardson

Affiliations

Maria Mancini: Champions Oncology, Hackensack, NJ, USA
Mara Gilardi: Champions Oncology, Hackensack, NJ, USA
Karin Abarca Heidemann: Champions Oncology, Hackensack, NJ, USA
Michael Ritchie: Champions Oncology, Hackensack, NJ, USA
Brandon Walling: Champions Oncology, Hackensack, NJ, USA
Haoting Hsu: Champions Oncology, Hackensack, NJ, USA
Jessica Pearl: Champions Oncology, Hackensack, NJ, USA
Megan Richardson: Champions Oncology, Hackensack, NJ, USA

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0476
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal